DenovAI Biotech

DenovAI Biotech is at the forefront of biotechnology research, dedicated to pioneering advancements in protein design for improved human health. With a focus on dynamic protein engineering, DenovAI Biotech leverages cutting-edge artificial intelligence and computational molecular biophysics to create innovative technology platforms. These platforms are designed to revolutionize the creation of high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters, all precisely tailored to bind to specific targets.

Located at AION Labs, 4 Oppenheimer, Rehovot, 7670104, IL, DenovAI Biotech is committed to transforming the landscape of therapeutic development. The company's AI-based platform accelerates the discovery process for de novo antibodies, reducing timelines from months to days and expanding therapeutic possibilities across numerous diseases. By building on recent innovations, DenovAI Biotech designs bespoke high-affinity binders for a multitude of targets, unlocking significant applications in biologics and diagnostics.

DenovAI Biotech is dedicated to pushing the boundaries of what is possible in protein design. DenovAI Biotech is actively developing its capabilities to better serve its partners and the broader scientific community. We invite the manager of DenovAI Biotech to create a customized and exclusive company showcase and product listing on our platform to highlight these exciting advancements.